blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2841101

EP2841101 - COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  05.07.2019
FormerGrant of patent is intended
Status updated on  17.02.2019
FormerExamination is in progress
Status updated on  18.08.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
University Of Chicago
5801 S. Ellis
Chicago, IL 60637 / US
[2015/10]
Inventor(s)01 / McADOW, Molly
c/o University of Chicago
5801 S. Ellis
Chicago, IL 60637 / US
02 / EMOLO, Carla
c/o University of Chicago
5801 S. Ellis
Chicago, IL 60637 / US
03 / MISSIAKAS, Dominique, M.
c/o University of Chicago
5801 S. Ellis
Chicago, IL 60637 / US
04 / SCHNEEWIND, Olaf
c/o University of Chicago
5801 S. Ellis
Chicago, IL 60637 / US
 [2015/10]
Representative(s)Bösl, Raphael Konrad
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstraße 4
68163 Mannheim / DE
[N/P]
Former [2019/32]Bösl, Raphael Konrad
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
Former [2015/10]Bösl, Raphael Konrad
Isenbruck Bösl Hörschler LLP
Patentanwälte
Prinzregentenstraße 68
81675 München / DE
Application number, filing date13781905.815.03.2013
[2019/32]
WO2013US31927
Priority number, dateUS201261638797P26.04.2012         Original published format: US 201261638797 P
[2015/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013162751
Date:31.10.2013
Language:EN
[2013/44]
Type: A1 Application with search report 
No.:EP2841101
Date:04.03.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 31.10.2013 takes the place of the publication of the European patent application.
[2015/10]
Type: B1 Patent specification 
No.:EP2841101
Date:07.08.2019
Language:EN
[2019/32]
Search report(s)International search report - published on:KR31.10.2013
(Supplementary) European search report - dispatched on:EP22.01.2016
ClassificationIPC:A61K39/395, A61K38/17, A61P31/04, A61P31/00, C07K14/31, C07K16/12
[2015/38]
CPC:
C07K16/1271 (EP,US); A61P31/00 (EP); A61P31/04 (EP);
A61K38/00 (EP,US); C07K2317/24 (US); C07K2317/33 (EP,US);
C07K2317/565 (US); C07K2317/569 (US); C07K2317/76 (EP,US);
C07K2317/92 (EP,US) (-)
Former IPC [2015/10]A61K39/395, A61K38/17, A61P31/04, A61P31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/10]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN IN ZUSAMMENHANG MIT ANTIKÖRPERN ZUR NEUTRALISIERUNG DER KOAGULASEAKTIVITÄT BEI EINER STAPHYLOCOCCUS-AUREUS-ERKRANKUNG[2015/10]
English:COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE[2015/10]
French:COMPOSITIONS ET PROCÉDÉS ASSOCIÉS À DES ANTICORPS QUI NEUTRALISENT L'ACTIVITÉ COAGULASE DANS UNE MALADIE À STAPHYLOCOCCUS AUREUS[2015/10]
Entry into regional phase25.11.2014National basic fee paid 
25.11.2014Search fee paid 
25.11.2014Designation fee(s) paid 
25.11.2014Examination fee paid 
Examination procedure25.11.2014Examination requested  [2015/10]
18.08.2016Amendment by applicant (claims and/or description)
18.08.2017Despatch of a communication from the examining division (Time limit: M02)
27.10.2017Reply to a communication from the examining division
12.12.2018Cancellation of oral proceeding that was planned for 13.12.2018
13.12.2018Date of oral proceedings (cancelled)
18.02.2019Communication of intention to grant the patent
27.06.2019Fee for grant paid
27.06.2019Fee for publishing/printing paid
27.06.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.08.2017
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
10.03.2015Renewal fee patent year 03
10.03.2016Renewal fee patent year 04
10.03.2017Renewal fee patent year 05
13.03.2018Renewal fee patent year 06
28.06.2019Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.03.201907   M06   Fee paid on   28.06.2019
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.03.2013
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
[2022/32]
Former [2022/27]HU15.03.2013
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/12]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE15.03.2020
LU15.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/07]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE15.03.2020
LU15.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/04]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
LU15.03.2020
Former [2020/49]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/37]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/36]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/27]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/25]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/24]AL07.08.2019
AT07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/23]AL07.08.2019
AT07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
IT07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/22]AL07.08.2019
DK07.08.2019
EE07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/17]AL07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/15]AL07.08.2019
ES07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/12]ES07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/11]ES07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/10]FI07.08.2019
LT07.08.2019
NL07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
PT09.12.2019
Former [2020/09]FI07.08.2019
LT07.08.2019
NL07.08.2019
NO07.11.2019
Former [2020/08]LT07.08.2019
NO07.11.2019
Documents cited:Search[I]WO2011005341  (UNIV CHICAGO [US], et al) [I] 1-15 * claims 97, 98, 113, 144;; claims 1-10 *;
 [I]  - ALICE G. CHENG ET AL, "Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity", PLOS PATHOGENS, (20100101), vol. 6, no. 8, doi:10.1371/journal.ppat.1001036, pages 1 - 18, XP055174922 [I] 1-15 * abstract * * Tab 2-4, Fig. 6; p 7, rhc; p 11lhc, 2nd par *

DOI:   http://dx.doi.org/10.1371/journal.ppat.1001036
 [I]  - ANDREA DEDENT ET AL, "Exploringpathways to disease for vaccine development", SEMINARS IN IMMUNOPATHOLOGY, SPRINGER, BERLIN, DE, (20111201), vol. 34, no. 2, doi:10.1007/S00281-011-0299-Z, ISSN 1863-2300, pages 317 - 333, XP035012130 [I] 1-15 * p 325, lhc, par 2 *

DOI:   http://dx.doi.org/10.1007/s00281-011-0299-z
 [I]  - MOLLY MCADOW ET AL, "Staphylococcus aureus Secretes Coagulase and von Willebrand Factor Binding Protein to Modify the Coagulation Cascade and Establish Host Infections", JOURNAL OF INNATE IMMUNITY, (20120101), vol. 4, no. 2, doi:10.1159/000333447, ISSN 1662-811X, pages 141 - 148, XP055174923 [I] 1-15 * p 143, rhc, end of par 2; p 146, lhc *

DOI:   http://dx.doi.org/10.1159/000333447
 [IDP]  - M. MCADOW ET AL, "Coagulases as Determinants of Protective Immune Responses against Staphylococcus aureus", INFECTION AND IMMUNITY, (20120723), vol. 80, no. 10, doi:10.1128/IAI.00562-12, ISSN 0019-9567, pages 3389 - 3398, XP055174928 [IDP] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1128/IAI.00562-12
 [A]  - MOLLY MCADOW ET AL, "Preventing Staphylococcus aureus Sepsis through the Inhibition of Its Agglutination in Blood", PLOS PATHOGENS, (20111020), vol. 7, no. 10, doi:10.1371/journal.ppat.1002307, page e1002307, XP055206042 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.ppat.1002307
 [A]  - FRIEDRICH R ET AL, "Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation", NATURE, NATURE PUBLISHING GROUP, UNITED KINGDOM, (20031001), vol. 425, no. 6957, ISSN 0028-0836, pages 535 - 539, XP008129241 [A] 1-15 * the whole document *
 [A]  - LISA L. LORENZ ET AL, "Staphylococcal Coagulase: Mode of Action and Antigenicity", MICROBIOLOGY, GB, (19520201), vol. 6, no. 1-2, doi:10.1099/00221287-6-1-2-95, ISSN 1350-0872, pages 95 - 107, XP055240995 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1099/00221287-6-1-2-95
International search[A]US2010183623  (PATTI JOSEPH M [US], et al);
 [A]US2011059085  (KIM STANLEY A [US]);
 [A]  - CHENG, A. G. ET AL., "Contribution of coagulases towards Staphylococcus aureus disease and protective immunity", PLOS PATHOGENS, (2010), vol. 6, no. 8, XP055174922

DOI:   http://dx.doi.org/10.1371/journal.ppat.1001036
 [A]  - MCADOW, M. ET AL., "Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections", JOURNAL OF INNATE IMMUNITY, (20120103), vol. 4, pages 141 - 148, XP055174923

DOI:   http://dx.doi.org/10.1159/000333447
 [A]  - WATANABE, S. ET AL., "Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus", JOURNAL OF BACTERIOLOGY, (2005), vol. 187, no. 11, pages 3698 - 3707, XP008101020

DOI:   http://dx.doi.org/10.1128/JB.187.11.3698-3707.2005
 [XP]  - MCADOW, M. ET AL., "Coagulases as determinants of protective immune responses against Staphylococcus aureus", INFECTION AND IMMUNITY, (20120723), vol. 80, no. 10, pages 3389 - 3398, XP055174928

DOI:   http://dx.doi.org/10.1128/IAI.00562-12
by applicantUS3817837
 US3850752
 US3939350
 US3996345
 US4196265
 US4275149
 US4277437
 US4338298
 US4366241
 US4472509
 US4554101
 EP0216846
 US4684611
 EP0256055
 US4748018
 EP0323997
 US4879236
 US4938948
 US4952500
 US5021236
 US5196066
 US5262357
 US5302523
 WO9409699
 US5322783
 US5384253
 WO9506128
 US5464765
 US5505928
 US5512282
 US5538877
 US5538880
 US5548066
 US5550318
 US5563055
 US5580859
 US5589466
 US5591616
 US5610042
 US5648240
 US5656610
 US5690807
 US5702932
 US5736524
 US5741957
 US5750172
 US5756687
 US5780448
 US5789215
 US5801234
 US5827690
 US5840846
 WO9857994
 US5871986
 WO9926299
 US5945100
 US5981274
 US5990479
 US5994624
 US6008341
 WO0002523
 WO0012689
 US6048616
 US6091001
 US6274323
 WO0160852
 US6288214
 US2002169288
 US6630307
 US6651655
 US6756361
 US6770278
 US2005106660
 US6936258
 US2006058510
 WO2006032472
 WO2006032475
 WO2006032500
 US2006088908
 WO2006056464
 WO2007113222
 WO2007113223
 WO2010042481
 US2010285564
 WO2011005341
 US2011262477
 US2012114686
 US2013132504
 US2014335095
 US2016175441
    - J. gen. Microbiol., (19520000), vol. 6, pages 95 - 107
    - "GenBank", Database accession no. CAC80837
    - "GenBank", Database accession no. AJ249487
    - "GenBank", Database accession no. NP _372518
    - "GenBank", Database accession no. NP_372518
    - Sherris medical microbiology : an introduction to infectious diseases, McGraw-Hill, (20040000), vol. xiii, page 979
    - LOWY FD, "Staphylococcus aureus infections", The New England journal of medicine, (19980000), vol. 339, pages 520 - 532
    - BOUCHER HW; COREY GR, "Epidemiology of methicillin-resistant Staphylococcus aureus", Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (20080000), vol. 46, no. 5, pages 344 - 349
    - CHU VH; CROSSLIN DR; FRIEDMAN JY; REED SD; CABELL CH et al., "Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes", The American journal of medicine, (20050000), vol. 118, doi:doi:10.1016/j.amjmed.2005.06.011, page 1416, XP005788049

DOI:   http://dx.doi.org/10.1016/j.amjmed.2005.06.011
    - KALLEN AJ; BRUNKARD J; MOORE Z; BUDGE P; ARNOLD KE et al., "Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season", Annals of emergency medicine, (20090000), vol. 53, doi:doi:10.1016/j.annemergmed.2008.04.027, pages 358 - 365, XP025954299

DOI:   http://dx.doi.org/10.1016/j.annemergmed.2008.04.027
    - GRAVENKEMPER CF; BRODIE JL; KIRBY WM, "Resistance of Coagulase-Positive Staphylococci to Methicillin and Oxacillin", Journal of bacteriology, (19650000), vol. 89, pages 1005 - 1010
    - SARAVOLATZ LD; POHLOD DJ; ARKING LM, "Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks", Annals of internal medicine, (19820000), vol. 97, pages 325 - 329
    - HEROLD BC; IMMERGLUCK LC; MARANAN MC; LAUDERDALE DS; GASKIN RE et al., "Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk", JAMA : the journal of the American Medical Association, (19980000), vol. 279, pages 593 - 598
    - NOBLE WC; VIRANI Z; CREE RG, "Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus", FEMS microbiology letters, (19920000), vol. 72, doi:doi:10.1111/j.1574-6968.1992.tb05089.x, pages 195 - 198, XP023921843

DOI:   http://dx.doi.org/10.1111/j.1574-6968.1992.tb05089.x
 EP19890303964
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.